EUVIMEDEUVIMED entdecken
Crossref

Splicing variants in DEPDC5 ‐related epilepsies: From functional characterization to correction

Evgeniya Osipova iD, Igor Bychkov iD, Alexandra Filatova iD, Artem Borovikov iD, Artem Sharkov iD, Snezhana Sharkova, Dmitriy Saushev iD, Ekaterina Lozier, Vyacheslav Tabakov, Mikhail Skoblov iD

Epilepsia · 2025-10 · 66 (10) · 3979-3991

DOI: 10.1111/epi.18506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 21.06.2025. Verfasst von Evgeniya Osipova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Genomics, Research Centre for Medical Genetics, Moscow, Russia. Hauptthemen laut MEDLINE: GTPase-Activating Proteins, RNA Splicing, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to investigate the role of splicing variants in the DEPDC5 gene, which is commonly associated with familial focal epilepsies. Although heterozygous germline variants in genes encoding components of the GAP activity toward Rags 1 (GATOR1) complex ( DEPDC5 , NPRL2 , and NPRL3 ) have been frequently identified in these cases, the effects of most previously identified variants on splicing remain unstudied. We focused on analyzing both intronic and exonic splicing variants and developing a potential correction strategy.

Methods

Gene panel, whole‐exome sequencing (WES), or whole‐genome sequencing (WGS) was used to identify pathogenic variants in four familial cases with DEPDC5 ‐related epilepsy, whereas RNA analysis evaluated their impact on splicing. For seven previously described variants, a functional analysis using a minigene expression system assessed their effects on splicing. A correction system using modified small nuclear RNAs (snRNAs) was developed to target one of the identified splicing variants.

Results

Two canonical splice‐site variants, missense and synonymous variants, were identified in DEPDC5 across affected families. Pathogenicity was confirmed for the exonic variants, and the molecular mechanisms of splicing disruption were elucidated for all four variants. Analysis of previously published DEPDC5 variants revealed that 13.6% of reported single nucleotide variants may affect splicing, including both intronic and exonic variants. Notably, approximately half of non‐canonical intronic splice region variants were predicted to have no impact on splicing, indicating a high likelihood of misannotation. Five missense and two nonsense previously reported DEPDC5 variants were functionally analyzed for their effect on splicing, revealing diverse mechanisms such as activation of cryptic splice sites and disruption of exonic splicing enhancers. For the c.3264G>A patient variant, a correction system using modified snRNAs successfully rescued normal splicing. Significance This study enhances understanding of splicing variants in the DEPDC5 gene and their role in focal epilepsies. The development of a correction system using modified snRNAs represents a novel therapeutic approach, laying the groundwork for personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTPase-Activating ProteinsRNA SplicingEpilepsyHumansMaleFemaleExome SequencingChildAdultWhole Genome SequencingRNA, Small Nuclear

Stichwörter der Autor:innen

DEPDC5RNA analysisminigene assaysplicingsplicing correction

Substanzen

DEPDC5 protein, humanGTPase-Activating ProteinsRNA, Small Nuclear

Autor:innen und Institutionen

  • Department of Functional Genomics, Research Centre for Medical Genetics, Moscow, Russia.
  • Department of Psychoneurology and Epileptology, Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University, Moscow, Russia.
  • Department of Neurology, Genomed, Moscow, Russia.
  • Department of Clinical Neurophysiology, Research Center of Neurology, Moscow, Russia.
  • Laboratory of Genomic Data Analysis, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia.

ORCID-Profile: Evgeniya Osipova, Igor Bychkov, Alexandra Filatova, Artem Borovikov, Artem Sharkov, Dmitriy Saushev, Mikhail Skoblov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Osipova, E., Bychkov, I., Filatova, A., Borovikov, A., Sharkov, A., Sharkova, S., Saushev, D., Lozier, E., Tabakov, V., & Skoblov, M. (2025). Splicing variants in DEPDC5 ‐related epilepsies: From functional characterization to correction. Epilepsia, 66(10), 3979-3991. https://doi.org/10.1111/epi.18506

Vancouver

Osipova E, Bychkov I, Filatova A, Borovikov A, Sharkov A, Sharkova S, et al. Splicing variants in DEPDC5 ‐related epilepsies: From functional characterization to correction. Epilepsia. 2025;66(10):3979-3991. doi:10.1111/epi.18506

BibTeX
@article{Osipova2025,
  author = {Osipova, Evgeniya and Bychkov, Igor and Filatova, Alexandra and Borovikov, Artem and Sharkov, Artem and Sharkova, Snezhana and Saushev, Dmitriy and Lozier, Ekaterina and Tabakov, Vyacheslav and Skoblov, Mikhail},
  title = {Splicing variants in DEPDC5 ‐related epilepsies: From functional characterization to correction},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {10},
  pages = {3979--3991},
  doi = {10.1111/epi.18506}
}
Kostenlos starten →